Amphastar Pharmaceuticals, Inc. officer William J Peters filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 16,000 shares of common stock via UBS Financial Services, Inc., acquired through the exercise of stock options on the same date.

Key Highlights

  • Proposed sale: 16,000 shares of Amphastar Pharmaceuticals common stock with an aggregate market value of $448,480.00, according to the filing.
  • Acquisition method: The 16,000 shares were acquired on November 4, 2026, through the exercise of stock options granted by the issuer, with cash payment on the same date.
  • Approximate sale date: November 4, 2026, to be executed through UBS Financial Services, Inc., located in Weehawken, NJ.
  • Shares outstanding: The filing reports 42,537,944 shares of common stock outstanding at the time of notice.
  • Prior sales in past 3 months: Peters sold 8,180 shares on August 7, 2026, for gross proceeds of $183,886.40, and 4,139 shares on September 21, 2026, for gross proceeds of $103,475.00.
  • Rule 10b5-1 plan: The filing indicates a trading plan adoption date of March 10, 2026.

Peters Files Rule 144 Notice for Proposed Option-Exercised Share Sale at Amphastar

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, William J Peters, identified as an officer of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), proposes to sell 16,000 shares of the company's common stock. The filing lists the aggregate market value of those shares at $448,480.00. The proposed transaction is to be carried out through UBS Financial Services, Inc., with an approximate sale date of November 4, 2026.

The filing discloses that the 16,000 shares subject to the proposed sale were acquired on November 4, 2026, through the exercise of stock options issued by the issuer, with the stated nature of payment being cash. The notice was signed by UBS Financial Services Inc. as attorney-in-fact for William J Peters. The filing also notes a Rule 10b5-1 plan adoption date of March 10, 2026, meaning the sale instructions were given under that plan as of that earlier date.

In the section covering securities sold during the past three months, the filing reports two prior transactions by Peters: a sale of 8,180 shares on August 7, 2026, with gross proceeds of $183,886.40, and a sale of 4,139 shares on September 21, 2026, with gross proceeds of $103,475.00. Both involved Amphastar common stock sold from the same address in Rancho Cucamonga, California, listed as the issuer's address.

What Was Disclosed

Amphastar Pharmaceuticals officer William J Peters filed a Form 144 notice proposing the sale of 16,000 common shares valued at $448,480.00, acquired via stock option exercise on November 4, 2026, through UBS Financial Services, Inc., under a Rule 10b5-1 plan adopted March 10, 2026.